motherlodetv.net
Cannabis investors have had a series of rude shocks in the past few months. Right now, people still believe in the cannabis opportunity are much more selective in their investment choices. They want companies with real assets, cash on hand, a real business plan, proprietary intellectual property and a well-defined market.
Anthony Durkacz has a unique perspective on Canada’s emerging cannabis industry. Through his First Republic Capital, he has financed FSD Pharma (C.HUGE), Canntab Therapeutics (C.PILL), Cannara Biotech (C.LOVE) and, now, World-Class Extractions (C.PUMP). In each case Durkacz has been looking for business models which go well beyond the simple cultivation of cannabis.
I like Anthony Durkacz. I’ve interviewed him several times for motherlodetv.net and he is very straightforward and tells the HUGE story well.
An interesting chart with the top performing cannabis stocks of 2018:
It is always nice to see a client do well. FSD Pharma (C.HUGE) is blazing a trail in the already hot marijuana space.
As the companies come up to the starting gate for the great Canadian recreational cannabis sweepstakes we are seeing huge interest in the sector. The investment of 5 billion dollars in Canopy Growth by Constellation Beverages re-ignited the marijuana stock market in Canada. All of a sudden, Canada’s world-wide lead in the creation and financing of cannabis businesses looked to have an international scope.
As the various Canadian Cannabis companies jockey for position in the recreational marijuana market it’s time to consider which are best placed to meet the market strategically.
I am writing a series of articles over at Seeking Alpha on the ins and outs of the Canadian marijuana market and the public companies which are working in this space. Article #2 is a worms eye view of the various sorts of users who make up that market including people who might grow their own.
Despite having written a book about the marijuana business, motherlodetv.net has not covered the burgeoning pot stock world. We may in the New Year. However, The Economist has an excellent, short, article about why American marijuana firms are looking to Canadian capital markets for their financing.